Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M111,852Revenue $M18,676Net Margin (%)25.7Z-Score2.4
Enterprise Value $M118,992EPS $6.6Operating Margin %31.6F-Score4
P/E(ttm))22.6Cash Flow Per Share $6.7Pre-tax Margin (%)28.2Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %11.3Quick Ratio4.0Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %9.5Current Ratio4.4Lower Leverage y-yY
Price/Cash Flow13.3y-y EBITDA Growth Rate %16.3ROA % (ttm)8.0Higher Current Ratio y-yN
Dividend Yield %1.6Insider Buy (3m)1ROE % (ttm)22.5Less Shares Outstanding y-yN
Payout Ratio %33.0Shares Outstanding M760ROI % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNDaniel Loeb 2014-06-30 Buy 0.65%$110.29 - $126.07
($115.72)
$ 147.2527%New holding, 450000 sh.450,000
AMGNJoel Greenblatt 2014-06-30 Buy 0.02%$110.29 - $126.07
($115.72)
$ 147.2527%New holding, 9938 sh.9,938
AMGNMario Gabelli 2014-06-30 Add0.02%$110.29 - $126.07
($115.72)
$ 147.2527%Add 85.28%60,335
AMGNKen Fisher 2014-06-30 Add0.01%$110.29 - $126.07
($115.72)
$ 147.2527%Add 71.02%85,316
AMGNJohn Hussman 2014-06-30 Reduce-0.93%$110.29 - $126.07
($115.72)
$ 147.2527%Reduce -66.67%50,000
AMGNKen Fisher 2014-03-31 Add0.01%$113.48 - $127.47
($120.95)
$ 147.2522%Add 754.67%49,887
AMGNMario Gabelli 2014-03-31 Add0.01%$113.48 - $127.47
($121.04)
$ 147.2522%Add 37.87%32,565
AMGNDodge & Cox 2014-03-31 Reduce$113.48 - $127.47
($121.04)
$ 147.2522%Reduce -22.59%105,757
AMGNPRIMECAP Management 2014-03-31 Reduce-0.46%$113.48 - $127.47
($121.04)
$ 147.2522%Reduce -9.42%32,161,744
AMGNVanguard Health Care Fund 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 147.2522%Reduce -6.4%8,213,855
AMGNJohn Hussman 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 147.2522%Reduce -14.29%150,000
AMGNJoel Greenblatt 2014-03-31 Sold Out -0.06%$113.48 - $127.47
($121.04)
$ 147.2522%Sold Out0
AMGNRay Dalio 2014-03-31 Sold Out -0.01%$113.48 - $127.47
($121.04)
$ 147.2522%Sold Out0
AMGNJoel Greenblatt 2013-12-31 Buy 0.06%$106.28 - $118.688
($113.73)
$ 147.2530%New holding, 23170 sh.23,170
AMGNRay Dalio 2013-12-31 Buy 0.01%$106.28 - $118.688
($113.73)
$ 147.2530%New holding, 7513 sh.7,513
AMGNVanguard Health Care Fund 2013-12-31 Reduce-0.76%$106.28 - $118.688
($113.73)
$ 147.2530%Reduce -18.43%8,775,155
AMGNJohn Hussman 2013-12-31 Reduce-0.45%$106.28 - $118.688
($113.73)
$ 147.2530%Reduce -30%175,000
AMGNJohn Hussman 2013-09-30 Add0.3%$95.81 - $117.521
($108.55)
$ 147.2536%Add 25%250,000
AMGNMario Gabelli 2013-09-30 Add$95.81 - $117.521
($108.55)
$ 147.2536%Add 26.95%22,420
AMGNPRIMECAP Management 2013-09-30 Reduce-0.22%$95.81 - $117.521
($108.55)
$ 147.2536%Reduce -4.11%35,812,225
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AMGN Joel Greenblatt 2014-06-309,93800.02New Buy
AMGN Daniel Loeb 2014-06-30450,0000.060.65New Buy
AMGN Mario Gabelli 2014-06-3060,3350.010.04+85.28%
AMGN Ken Fisher 2014-06-3085,3160.010.02+71.02%
AMGN PRIMECAP Management 2014-06-3031,853,8444.194.1-0.96%
AMGN Vanguard Health Care Fund 2014-06-308,049,4551.062.5-2%
AMGN Dodge & Cox 2014-06-3085,8570.010.01-18.82%
AMGN John Hussman 2014-06-3050,0000.010.45-66.67%
AMGN Mark Hillman 2013-12-317,91201.4-1.95%
Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patton Cynthia MSVP & CCO 2014-08-05Sell2,644$127.9715.07view
Harper Sean EEVP, Research & Development 2014-08-05Sell14,000$127.2915.68view
Dittrich Thomas J.W.VP, Finance & CAO 2014-05-21Sell4,130$112.8330.51view
Bradway Robert AChairman, CEO and President 2014-05-12Buy894$111.7731.74view
Michael A KellyActing CFO 2014-04-28Sell2,065$110.4533.32view
de Carbonnel FrancoisDirector 2014-03-06Sell1,000$126.6916.23view
HENDERSON REBECCA MDirector 2014-02-13Sell20,000$123.5319.2view
AMGEN INC10% Owner 2013-12-17Buy272,142$72003.57view
Balachandran MadhavanEVP, Operations 2013-09-04Sell18,000$112.7630.59view
BALTIMORE DAVIDDirector 2013-08-28Sell4,582$109.6634.28view

Press Releases about AMGN :

    Quarterly/Annual Reports about AMGN:

    News about AMGN:

    Articles On GuruFocus.com
    Daniel Loeb Comments on Amgen Inc Oct 22 2014 
    Third Point Q3 2014 Investor Letter Oct 22 2014 
    Amgen: Stronger Drug Portfolio with Acquisition Sep 22 2014 
    Insider Buys at Halozyme Look to Improve Stock Outlook Sep 18 2014 
    Weekly 52-Week Highs Highlight: ABT, SWK, LMT, AMGN Sep 13 2014 
    After Reaching All-Time Highs, How Can Gilead Sciences Continue growing? Aug 27 2014 
    Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca (AZN) Positive Data From May 11 2014 
    Amgen Inc: As Good as It Gets? Feb 20 2014 
    You Can No Longer Ignore Biotech Feb 07 2014 
    Mario Gabelli Comments on Amgen Inc. Jan 06 2014 

    More From Our Partners
    Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors Oct 17 2014 - BENZINGA

    More From Other Websites
    Amgen To Webcast 2014 Business Review Meeting On October 28 Oct 23 2014
    Amgen To Webcast 2014 Business Review Meeting On October 28 Oct 23 2014
    Amgen Announces Webcast of 2014 Third Quarter Financial Results Oct 23 2014
    Amgen Announces Webcast of 2014 Third Quarter Financial Results Oct 23 2014
    The Zacks Analyst Blog Highlights: AbbVie, Amgen, Regeneron, Pharmacyclics and Repros Therapeutics Oct 23 2014
    17 trades in 91 seconds Oct 22 2014
    Biotechs Show Fed Chief's Not Much Of A Stock Analyst Oct 22 2014
    Amgen Gains as Third Point Suggests Split Oct 22 2014
    Four Reasons Why Amgen Won't Break Up Oct 22 2014
    Amgen’s Boss Makes a Prime Breakup Target for Loeb Oct 22 2014
    Third Point's Daniel Loeb Tells Amgen it's Time to Break up Oct 22 2014
    Bernstein Analyst Was First on Amgen Split---But Missed Its 20% Rally Oct 22 2014
    Amgen: splitting hairs Oct 22 2014
    Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? Oct 22 2014
    Add Amgen to the List of Activist Targets Oct 22 2014
    A.M. Roundup: New Managed ETFs from Global X, J.P. Morgan; Loeb Calls For Amgen Break Up Oct 22 2014
    [video] Dan Loeb’s Third Point Takes Aim at Amgen Break Up Oct 22 2014
    [$$] Amgen: $100 Billion Activist Target Oct 22 2014
    Third Point urges Amgen to consider breakup Oct 21 2014
    Third Point urges Amgen to consider breakup Oct 21 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK